Select your language/region

Q-linea as an investment

Welcome to the Investor Relations section. Here we have gathered important information about Q-linea for existing investors and others who are interested in our business.

NASDAQ Stockholm(QLINEA): Quotes are delayed 15 minutes

2.43

SEK

2.97

percent

Q-linea as an investment

Q-linea as an investment

Welcome to the Investor Relations section. Here we have gathered important information about Q-linea for existing investors and others who are interested in our business.

NASDAQ Stockholm(QLINEA): Quotes are delayed 15 minutes

2.43

SEK

2.97

percent

Future-proof Healthcare

CEO Jonas Jarvius explains how Q-linea is intimately tied to his experiences of healthcare inequity, and how Q-linea is working to ensure we have sustainable and equitable healthcare, now and in the future.

 

 

Press releases

Regulatory press release

2024/05/27

Changed date for Interim Report

Regulatory press release

2024/05/15

Changed dates for Interim Report and Annual General Meeting

Press release

2024/05/03

Q-linea applies for a NTAP code for the US market
Q-linea AB (publ) (OMX:QLINEA) today announces that the company has applied for a unique New Technology Add-on Payment (NTAP)…
Read more >

Keep up to date – subscribe

Christer Samuelsson

Investor Relations

Phone: +46 18 444 36 10

Mobile: +46 70 600 15 20

christer.samuelsson@qlinea.com

. . .
The share

Information about Q-linea stock price and trading volume